Caisse de depot et placement du Quebec bought a new position in shares of Cabot Corporation (NYSE:CBT – Free Report) during the second quarter, HoldingsChannel.com reports. The firm bought 95,889 shares of the specialty chemicals company’s stock, valued at approximately $8,709,000.
Other large investors have also added to or reduced their stakes in the company. NewEdge Advisors LLC increased its stake in shares of Cabot by 2,559.5% in the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after purchasing an additional 947 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in Cabot by 32.5% during the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after acquiring an additional 108,645 shares during the period. Empowered Funds LLC raised its holdings in Cabot by 102.6% during the first quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock valued at $2,341,000 after acquiring an additional 14,260 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Cabot by 3.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock valued at $10,145,000 after acquiring an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. boosted its stake in shares of Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Analyst Ratings Changes
Several research analysts have weighed in on CBT shares. Mizuho upped their price target on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. JPMorgan Chase & Co. boosted their target price on shares of Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a report on Friday, August 7th. Truist Financial set a $100.00 target price on shares of Cabot in a research report on Wednesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st. Finally, Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $89.00.
Cabot Trading Down 1.1%
Shares of CBT opened at $83.67 on Friday. The stock has a market capitalization of $4.32 billion, a PE ratio of 23.57, a P/E/G ratio of 10.98 and a beta of 0.84. The company’s fifty day moving average is $87.62 and its 200 day moving average is $81.19. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $94.53.
Cabot (NYSE:CBT – Get Free Report) last released its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating the consensus estimate of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The business had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. During the same quarter last year, the business earned $1.90 earnings per share. Cabot’s quarterly revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Sell-side analysts expect that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.
Cabot Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be issued a $0.4725 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. Cabot’s dividend payout ratio (DPR) is presently 53.24%.
Insiders Place Their Bets
In other Cabot news, CEO Sean D. Keohane sold 2,779 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $85.50, for a total transaction of $237,604.50. Following the sale, the chief executive officer directly owned 288,873 shares of the company’s stock, valued at $24,698,641.50. The trade was a 0.95% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 3.08% of the stock is owned by insiders.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
See Also
- Five stocks we like better than Cabot
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
